Atlas Trials

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.

Clinical trial NCT02036060 · COMPLETED

Trial details

NCT number
NCT02036060
Sponsor
Spanish Oncology Genito-Urinary Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2014-02-07
Primary completion
2020-06-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.